Navigation Links
Blue Cross Reverses Position on Autism After Federal Court Litigation Intensifies

DETROIT, May 11 /PRNewswire/ -- In federal court litigation, Johns v Blue Cross Blue Shield of Michigan, Case no. 08-cv-12272, Plaintiff Christopher Johns contends that Blue Cross illegally denied behavioral therapy to his autistic son, even though it was covered by his insurance policy. Plaintiff alleged that Blue Cross claimed that such therapy was "experimental" even though it was based on well-accepted scientific principles and was administered by such prestigious hospitals as Beaumont Hospital. In fact, during deposition testimony filed in federal court today, Blue Cross' corporate representative and Medical Director, Dr. Calmaze Dudley, conceded that applied behavioral therapy was supported by the prestigious American Academy of Pediatrics and candidly admitted that he would want such therapy for his own children, if they had autism:

    Q.  Based on your research and your investigation, if you had a child
        with autism, would you want them to receive ABA therapy?

    A.  Probably.

In a motion filed today, seeking to compel Blue Cross to produce further witnesses and documents, Plaintiff's attorney, Gerard Mantese, was confident that he will establish that Blue Cross' defense to the lawsuit is meritless and is contradicted by significant medical and scientific evidence of the effectiveness of behavioral therapy.

After one year of federal court proceedings in the Johns case, Blue Cross today announced that it was offering new coverage for the treatment of children with autism. Plaintiff's attorney, Gerard Mantese, stated: "We are pleased that the pressure of our lawsuit has caused Blue Cross to take a step toward doing the right thing for these families. In fact, Blue Cross first mentioned to us last year that it would be providing some treatment coverage to autistic children, after we began filing papers in our federal court lawsuit. We are confident that our litigation will cause Blue Cross to provide further relief to families who have been arbitrarily denied coverage for a scientifically established treatment that allows these children to achieve greater levels of self-sufficiency."

    For further information, please contact:

    Gerard Mantese
    Mantese and Rossman, P.C.
    1361 E. Big Beaver Road
    Troy, Michigan 48083
    248-457-9200 (office)
    248-515-6419 (cell)

SOURCE Mantese and Rossman, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross Blue Shield of Michigan Plans to Offer Customer Groups Ability to Purchase Coverage of Autism Treatment Programs that Provide Intensive Early Intervention
2. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
3. Blue Cross and Blue Shield Funds Diabetes Education at Saints Mary and Elizabeth Medical Center
4. Anthem Blue Cross to Support Members and Communities Impacted by Santa Barbara Fires
5. SAMHSA Honors Goldie Hawn, Youth Across the Country in Celebration of National Childrens Mental Health Awareness Day
6. Northwestern Mutual Foundation Announces $500,000 Disaster Relief Donation for the American Red Cross
7. Fitness Industry Leaders Across the Nation Gather on Capitol Hill to Campaign for a Healthier America
8. Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe
9. Swine Flu Continues to Spread Across U.S.
10. Blue Cross Blue Shield of Michigan and Blue Care Network Launch Web Sites to Help Chrysler Members Easily Find Information on Their Health Care
11. GNC Helps to Raise Over $300,000 for National MS Society in First 30 Days of Ride Across America by Phil Keoghan of CBS The Amazing Race
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: